| 1 | in the sense of | | | | | | | 2 | 0.44% |
| 2 | the sense of the | | | | | | | 2 | 0.44% |
| 3 | openclose menu biometric biometric | | | | | | 1 | 0.22% |
| 4 | in uppsala and stockholm | | | | | | | 1 | 0.22% |
| 5 | dental care team timo | | | | | | | 1 | 0.22% |
| 6 | professional dental care team | | | | | | | 1 | 0.22% |
| 7 | in professional dental care | | | | | | | 1 | 0.22% |
| 8 | technology in professional dental | | | | | | | 1 | 0.22% |
| 9 | attended studies in uppsala | | | | | | | 1 | 0.22% |
| 10 | studies in uppsala and | | | | | | | 1 | 0.22% |
| 11 | implant system together with | | | | | | | 1 | 0.22% |
| 12 | system together with innovative | | | | | | | 1 | 0.22% |
| 13 | and attended studies in | | | | | | | 1 | 0.22% |
| 14 | quality implant system together | | | | | | | 1 | 0.22% |
| 15 | high quality implant system | | | | | | | 1 | 0.22% |
| 16 | a high quality implant | | | | | | | 1 | 0.22% |
| 17 | offer a high quality | | | | | | | 1 | 0.22% |
| 18 | uppsala and stockholm universities | | | | | | | 1 | 0.22% |
| 19 | vision we evolve and | | | | | | | 1 | 0.22% |
| 20 | care team timo paberit | | | | | | | 1 | 0.22% |
| 21 | menu biometric biometric | | | | | | 1 | 0.22% |
| 22 | projects and attended studies | | | | | | | 1 | 0.22% |
| 23 | she has participated linguistic | | | | | | | 1 | 0.22% |
| 24 | practitioner in private implant | | | | | | | 1 | 0.22% |
| 25 | clinical practitioner in private | | | | | | | 1 | 0.22% |
| 26 | a clinical practitioner in | | | | | | | 1 | 0.22% |
| 27 | is a clinical practitioner | | | | | | | 1 | 0.22% |
| 28 | timo is a clinical | | | | | | | 1 | 0.22% |
| 29 | protocols timo is a | | | | | | | 1 | 0.22% |
| 30 | university she has participated | | | | | | | 1 | 0.22% |
| 31 | has participated linguistic research | | | | | | | 1 | 0.22% |
| 32 | industry our vision we | | | | | | | 1 | 0.22% |
| 33 | research evaluation processes and | | | | | | | 1 | 0.22% |
| 34 | clinical research evaluation processes | | | | | | | 1 | 0.22% |
| 35 | development clinical research evaluation | | | | | | | 1 | 0.22% |
| 36 | businessproduct development clinical research | | | | | | | 1 | 0.22% |
| 37 | dds timo’s responsibilities are | | | | | | | 1 | 0.22% |
| 38 | md dds timo’s responsibilities | | | | | | | 1 | 0.22% |
| 39 | founderpresident md dds timo’s | | | | | | | 1 | 0.22% |
| 40 | our vision we evolve | | | | | | | 1 | 0.22% |